Other OTC - Delayed Quote USD

Can B Corp. (CANB)

0.0260 -0.0025 (-8.40%)
As of 2:32 PM EDT. Market Open.
Loading Chart for CANB
DELL
  • Previous Close 0.0285
  • Open 0.0285
  • Bid --
  • Ask --
  • Day's Range 0.0260 - 0.0285
  • 52 Week Range 0.0120 - 0.8900
  • Volume 104,465
  • Avg. Volume 320,095
  • Market Cap (intraday) 1.283M
  • Beta (5Y Monthly) 1.49
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7700
  • Earnings Date Jun 4, 2024 - Jun 19, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website. The company also produces industrial hemp, and processes hemp biomass, isolate, and isomers, such as CBN, CBG, delta-8, and delta-10; and manufactures and sells durable medical equipment. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in January 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.

www.canbcorp.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CANB

Performance Overview: CANB

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CANB
3.70%
S&P 500
9.90%

1-Year Return

CANB
93.07%
S&P 500
27.10%

3-Year Return

CANB
99.57%
S&P 500
27.46%

5-Year Return

CANB
99.99%
S&P 500
86.42%

Compare To: CANB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CANB

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    1.41M

  • Enterprise Value

    18.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -36.43%

  • Return on Equity (ttm)

    -1,148.32%

  • Revenue (ttm)

    2.16M

  • Net Income Avi to Common (ttm)

    -9.74M

  • Diluted EPS (ttm)

    -0.7700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    34.01k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.35M

Research Analysis: CANB

Company Insights: CANB

Research Reports: CANB

People Also Watch